PEPTOMYC

«La bióloga que desafió la proteína “intocable” del cáncer»: el Diari Ara dedica un perfil a nuestra CSO, @LauraSoucek

Peptomyc's management team attended the ESMO Congress 2026 in Madrid, where we held a series of productive meetings with leading pharmaceutical companies. We are grateful for the constructive discussions and look forward to building on these conversations.
#ESMO2026 #Oncology

Peptomyc is pleased to announce its participation in the #ESMO26, taking place in Madrid from 23 to 27 October. @peptomyc will be represented by: @jesmartingarcia, CEO; @LauraSoucek, CSO; and Stephan Braun, CMO. Join us!
🔗lnkd.in/eXTzGgG8
#Oncology #MYC #Biotech

Yesterday, 29 September, our CEO @jesmartingarcia took the stage at #BIOSPAIN2026 in Bilbao to present Peptomyc to investors, partners and industry leaders from across the global biotech community. @BIOSPAIN_AseBio #MYC #Oncology #Biotechnology

📢 Peptomyc Closes €5.7 Million Financing Round as Catalan Public Investor ICF @icfcat Joins Its Shareholder Base.
shorturl.at/XbfqF